Genetic heterogeneity in cardiovascular disease across ancestries: Insights for mechanisms and therapeutic intervention
Cambridge Prisms: Precision Medicine · 2023
DOI: 10.1017/pcm.2022.13 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cambridge Prisms: Precision Medicine, 2023. Verfasst von Opeyemi Soremekun und 4 weiteren Autor:innen. Beteiligte Einrichtung: The African Computational Genomics (TACG) Research Group, Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and T…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, British Heart Foundation.
Abstract (Originalsprache)
Cardiovascular diseases (CVDs) are complex in their aetiology, arising due to a combination of genetics, lifestyle and environmental factors. By nature of this complexity, different CVDs vary in their molecular mechanisms, clinical presentation and progression. Although extensive efforts are being made to develop novel therapeutics for CVDs, genetic heterogeneity is often overlooked in the development process. By considering molecular mechanisms at an individual and ancestral level, a richer understanding of the influence of environmental and lifestyle factors can be gained and more refined therapeutic interventions can be developed. It is therefore expedient to understand the molecular and clinical heterogeneity in CVDs that exists across different populations. In this review, we highlight how the mechanisms underlying CVDs vary across diverse population ancestry groups due to genetic heterogeneity. We then discuss how such genetic heterogeneity is being leveraged to inform therapeutic interventions and personalised medicine, highlighting examples across the CVD spectrum. Finally, we present an overview of how polygenic risk scores and Mendelian randomisation can foster more robust insight into disease mechanisms and therapeutic intervention in diverse populations. Fulfilment of the vision of precision medicine requires more exhaustive leveraging of the genetic variability across diverse ancestry populations to improve our understanding of disease onset, progression and response to therapeutic intervention.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The African Computational Genomics (TACG) Research Group, Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe, Uganda.
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
- Molecular Bio-Computation and Drug Design Laboratory, School of Health Sciences, University of KwaZulu-Natal, Westville Campus, Durban, South Africa.
- British Heart Foundation Centre of Excellence, Imperial College London, London, UK.
- Centre for Evidence-Based Medicine, University of Oxford, Oxford, UK.
- Faculty of Medicine, Imperial College London, London, UK.
ORCID-Profile: Dipender Gill
Förderung
- Wellcome Trust
- British Heart Foundation
Zitieren
APA
Soremekun, O., Dib, M. J., Rajasundaram, S., Fatumo, S., & Gill, D. (2023). Genetic heterogeneity in cardiovascular disease across ancestries: Insights for mechanisms and therapeutic intervention. Cambridge Prisms: Precision Medicine. https://doi.org/10.1017/pcm.2022.13
Vancouver
Soremekun O, Dib MJ, Rajasundaram S, Fatumo S, Gill D. Genetic heterogeneity in cardiovascular disease across ancestries: Insights for mechanisms and therapeutic intervention. Cambridge Prisms: Precision Medicine. 2023. doi:10.1017/pcm.2022.13
BibTeX
@article{Soremekun2023,
author = {Soremekun, Opeyemi and Dib, Marie-Joe and Rajasundaram, Skanda and Fatumo, Segun and Gill, Dipender},
title = {Genetic heterogeneity in cardiovascular disease across ancestries: Insights for mechanisms and therapeutic intervention},
journal = {Cambridge Prisms: Precision Medicine},
year = {2023},
doi = {10.1017/pcm.2022.13}
}
EUVIMED